Sign in

You're signed outSign in or to get full access.

Michael Wilson

Chief Commercial Officer at BlueLinx HoldingsBlueLinx Holdings
Executive

About Michael Wilson

Michael Wilson, 62, is BlueLinx’s Chief Commercial Officer (CCO) since April 1, 2024, after previously serving as Chief Product Management Officer, SVP Product Management, VP Specialty Products, and VP Sales; prior roles include VP of Sales at Cedar Creek (1995–2018) and General Manager at Allison Sales Company . For fiscal 2024, Company performance against STIP metrics delivered Adjusted EBITDA of $131.355 million and ROWC of 28.3%, resulting in a 99.74% payout of target for all NEOs, including Wilson . Company five-year TSR (value of $100 initial investment) stood at 788.75 as of FY2024; Adjusted EBITDA was among the most important pay-performance linkages disclosed .

Past Roles

OrganizationRoleYearsStrategic Impact
BlueLinx Holdings (BXC)Chief Commercial OfficerApr 2024–presentPromoted to CCO; responsible for commercial strategy and growth initiatives .
BlueLinx Holdings (BXC)Chief Product Management Officer; SVP Product Management; VP Specialty Products; VP Salesn/d (prior to Apr 2024)“Played key roles in the Company’s growth” across product and sales leadership .
Cedar Creek Holdings Inc.VP Sales; VP Eastern Region; Regional Manager; General Manager1995–2018Senior commercial and regional leadership prior to BlueLinx acquisition of Cedar Creek in 2018 .
Allison Sales CompanyGeneral Managern/dGeneral management role prior to Cedar Creek .

External Roles

  • None disclosed in company filings .

Fixed Compensation

Component2024 Amount / LevelNotes
Base Salary (earned FY2024)$443,423Reflects $410,000 as CPdMO through Mar 31, 2024, and $455,000 as CCO from Apr 1, 2024 .
Current Annual Salary Rate$455,000Per CCO offer letter .
Target STIP (as % of salary)65%Per offer letter and STIP design for 2024 .
Actual STIP Paid (FY2024)$288,012As reported in Summary Compensation Table .
STIP Payout Factor (FY2024)99.74% of targetDriven by Adj. EBITDA and ROWC outcomes .
All Other Compensation (FY2024)$10,855As reported in Summary Compensation Table .

Performance Compensation

STIP (Annual Incentive) – FY2024 Design and Outcome

MetricWeightThresholdTargetMaximumActual FY2024Payout Impact
Adjusted EBITDA (TTM, $mm)60%$113.5$133.6$200.3+$131.355Slightly below Target; contributed to 99.74% overall payout .
Return on Working Capital (ROWC)40%23%27.1%40.7%28.3%Between Target and Maximum; contributed to 99.74% overall payout .
  • 2024 STIP payout to NEOs equaled 99.74% of target; Wilson’s Non-Equity Incentive Compensation was $288,012 .

LTIP (Equity Incentives) – Structure and Grants

  • Vehicles and metrics:
    • Time-based RSUs: vest in three equal annual installments, generally over three years .
    • Performance-based RSUs (PRSUs): 3-year performance period; cumulative Adjusted EBITDA (60%) and average ROWC (40%); 30%/100%/200% payout at Threshold/Target/Maximum; vest upon Committee certification after the 3-year period .
2024 Grant (June 7, 2024)Units (Target)Grant-Date Fair Value ($)
PRSUs (performance-based)2,912$284,357 .
RSUs (time-based)2,912$284,357 .
  • Vesting schedules (time-based RSUs):
    • 3,060 grant (2022): final 1,020 vesting remained after June 30, 2024 installment .
    • 3,344 grant (2023): two installments remaining beginning June 7, 2024 .
    • 2,912 grant (2024): three equal annual installments beginning June 7, 2025 .

Outstanding/Unvested Equity at FY2024 Year-End (12/28/2024)

Award TypeUnvested Units (#)Market Value ($)Notes
Time-based RSUs6,161$639,019Valued at $103.72 (12/28/2024 close) .
PRSUs (unearned)9,316$966,256PRSUs from 2022, 2023, 2024 cycles .
  • Stock options: None outstanding; company granted no options in FY2024 .

Equity Ownership & Alignment

ItemDetail
Beneficial Ownership (3/18/2025)1,900 shares; <1% of outstanding (8,180,454 shares outstanding on record date) .
Unvested/Unearned Equity6,161 unvested RSUs; 9,316 unearned PRSUs at FY-end 2024 .
Ownership GuidelinesC-level executives reporting to CEO: 2x base salary; must hold all shares (including vesting shares) until in compliance; compliance monitored annually .
Hedging / PledgingProhibited for all directors, officers, employees; also bans margin accounts/pledges; pre-clearance and blackout rules apply .

Employment Terms

  • Offer Letter (effective with CCO role on April 1, 2024):
    • Base salary $455,000; target STIP 65% of salary; annual LTIP eligibility equal to 125% of salary, split 50% PRSUs / 50% RSUs (priced off 30-day average); standard executive benefits .
  • Severance / Change in Control:
    • Covered by Executive Severance Plan: upon termination without cause or for good reason (non-CIC), 12 months of severance pay plus pro-rata STIP based on actual performance, subject to release; certain perquisites and restrictive covenants apply .
    • If termination without cause/for good reason in connection with a Change in Control: salary-and-incentive equals one times current base plus pro rata STIP; 12 months of medical coverage; full vesting of unvested time-based RSUs and PRSUs under CIC table assumptions (values based on $103.72) .
  • Restrictive Covenants:
    • General: non-compete for 1 year; non-solicitation (employees, customers/vendors) for 2 years post-termination; confidentiality and non-interference covenants .
  • Clawback:
    • SEC/NYSE-compliant policy to recover erroneously awarded incentive-based compensation for three fiscal years preceding a required restatement; multiple recovery methods; no indemnification permitted .

Investment Implications

  • Alignment: Wilson’s package is heavily performance-linked via STIP (Adj. EBITDA 60% / ROWC 40%) and PRSUs using 3-year cumulative Adjusted EBITDA and average ROWC metrics; 2024 payout at 99.74% indicates targets set near achieved performance .
  • Retention/Overhang: Significant unvested equity (6,161 RSUs) plus multi-year PRSUs (9,316) create vesting-driven retention; annual RSU vesting cadence may produce periodic, manageable selling supply as restrictions lapse .
  • Risk Controls: Prohibitions on hedging/pledging, stock ownership guidelines (2x salary for C-level), and a robust clawback reduce misalignment and selling pressure risks from leverage or hedging .
  • Change-in-Control Economics: CIC table indicates potential aggregate of $2.35 million for Wilson (salary/incentive, medical, and accelerated equity), which is modest vs CEO multiples and suggests retention yet limited windfall risk; non-CIC severance equals 12 months plus pro-rata STIP, with no equity acceleration .
  • Governance Signals: No options granted in 2024 (lower risk of repricing); 2024 say-on-pay support exceeded 95%, indicating broad shareholder approval of compensation design .

Performance Compensation – Detailed Reference Table

ElementMetric/TermWeightingTarget/GrantActual/StatusVesting
STIP FY2024Adjusted EBITDA60%$133.6mm$131.355mmAnnual cash; paid at 99.74% of target .
STIP FY2024ROWC40%27.1%28.3%Annual cash; paid at 99.74% of target .
2024 PRSUsCum. Adj EBITDA / Avg ROWC60% / 40%2,912 units; $284,357Unvested (3-year)Cliff vest after 3-year period upon certification (30%/100%/200%) .
2024 RSUsTime-based2,912 units; $284,357UnvestedThree equal annual installments beginning 6/7/2025 .
Outstanding at FY-endTime-based RSUs6,161 units$639,019As of 12/28/2024 at $103.72 .
Outstanding at FY-endPRSUs9,316 units$966,256As of 12/28/2024 at $103.72 .

Equity Ownership & Alignment – Detailed Reference

ItemDetail
Shares Beneficially Owned (3/18/2025)1,900; <1% of 8,180,454 outstanding .
Ownership Guidelines2x salary for C-level; mandatory hold until met; annual monitoring .
Hedging/PledgingProhibited (including collars/swaps/prepaid forwards); no margin/pledge accounts; trading pre-clearance and blackout policy .

Employment Terms – Detailed Reference

ProvisionTerm
Base Salary (CCO)$455,000 .
Target STIP65% of base salary .
LTIP Target Mix125% of salary; 50% PRSUs / 50% RSUs .
Severance (non-CIC)12 months salary plus pro-rata STIP based on actual performance; 12 months medical COBRA reimbursement for executives as applicable; subject to release .
CIC TerminationOne times salary plus pro-rata STIP; 12 months medical; full acceleration of time-based and performance-based RSUs (values shown in table) .
Restrictive Covenants1-year non-compete; 2-year non-solicit; confidentiality/non-interference .
ClawbackSEC/NYSE clawback for erroneously awarded incentive comp; no indemnification .

Notes:

  • Michael Wilson’s 2024 compensation as disclosed: Salary $443,423; Stock Awards $568,714; Non-Equity Incentive Comp $288,012; All Other Comp $10,855; Total $1,311,004 .
  • No options exercised or granted in 2024; Company granted no options in FY2024 .

Citations: